Fortis Healthcare Limited Earnings Summary — Q4 FY2026
Fortis Healthcare Achieves Robust Revenue Growth in Q4 FY26 Amid Margin Expansion
Key Takeaways
- Revenue grew 17.8% YoY to ₹2,365 Crores, maintaining a steady quarterly growth trajectory.
- Net Profit surged 44% compared to the same quarter last year, reaching ₹271 Crores.
- Operating Profit Margin (OPM) improved to 23%, reflecting effective clinical and cost optimization.
- Borrowings increased significantly to ₹3,473 Crores by the end of Mar 2026, up from ₹2,475 Crores YoY.
- Interest expenses rose to ₹84 Crores in the current quarter, a significant jump from ₹68 Crores in Mar 2025.
- Tax rate fluctuated down to 16% in Q4 FY26, contributing to the healthy Net Profit figure.
- The hospital business continues to benefit from a dual-engine model alongside the Agilus diagnostic chain.
Management Guidance
Management aims to increase bed capacity to over 4,000, focusing on medical value travel and premium healthcare services under IHH stewardship.
Sentiment Shift
Improving
The company has transitioned from governance distress to a high-margin healthcare infrastructure play with consistent profit growth and operational leverage.
Outlook
The outlook remains positive with expectations of continued multi-hundred crore profits and institutional focus on ARPOB expansion through medical tourism and bed capacity growth.
From the Annual Report (Key Quotes)
“Under IHH Healthcare’s stewardship, the management has successfully repaired the company’s reputation.”
“The underlying operational turnaround is one of the most significant in the Indian healthcare sector.”
“There is a clear strategic vision to increase bed capacity to 4,000+ while focusing on 'medical value travel'.”
Earnings Call Transcript — Q4 FY2026
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Fortis Healthcare Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.